{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:21:01Z","timestamp":1787772061295,"version":"build-2784847793"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Progestogen hypersensitivity (PH) also known as autoimmune progesterone dermatitis is a rare clinical entity that may be triggered by endogenous progesterone (menstrual cycles and pregnancy) or exogenous progestin exposure (examples: contraceptive medicines,\n                    <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                    fertilization treatments). It is a poorly recognized syndrome due to its heterogeneous clinical presentation. The pathomechanism of PH is believed to be primarily IgE mediated but less commonly other immune responses may be involved. Management is usually focused on symptomatic control with medications. Recently, with the increasing use of exogenous progestins for\n                    <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                    fertilization more cases of hypersensitivity to exogenous progestins have been reported. Progesterone is an essential drug in the luteal phase support improving chances of implantation and pregnancy rates, and hence, PH is an important and difficult challenge to manage in these patients. Because patients require IVF and there is no alternative to progesterone, desensitization is suggested as an approach to endure fertility treatments and provides symptom control in refractory cases. Here, we will review the different aspects of PH.\n                  <\/jats:p>","DOI":"10.4103\/idoj.idoj_664_22","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T09:01:34Z","timestamp":1710406894000},"page":"24-32","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Exogenous Progestogen Hypersensitivity and its Increasing Association with Assisted Reproductive Techniques (ART)\/in vitro Fertilization (IVF)"],"prefix":"10.4103","volume":"15","author":[{"given":"Nivedita","family":"Sashidhar","sequence":"first","affiliation":[{"name":"Venkat Center for Skin and Plastic Surgery, Department of Dermatology, Vijayanagar, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkataram","family":"Mysore","sequence":"additional","affiliation":[{"name":"Venkat Center for Skin and Plastic Surgery, Department of Dermatology, Vijayanagar, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. V.","family":"Thejavathy","sequence":"additional","affiliation":[{"name":"Bhagwan Mahaveer Jain Hospital, Department of OBG, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jama.1964.03070140041004","article-title":"Autoimmune progesterone dermatitis. Cure by oophorectomy","volume":"190","author":"Shelley","year":"1964","journal-title":"JAMA"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaip.2016.03.003","article-title":"Progestogen hypersensitivity in 24 cases: Diagnosis, management, and proposed renaming and classification","volume":"4","author":"Foer","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jri.2013.04.006","article-title":"Skin test reactivity to female sex hormones in women with primary unexplained recurrent pregnancy loss","volume":"99","author":"Ellaithy","year":"2013","journal-title":"J Reprod Immunol"},{"key":"R4-20240828","first-page":"183","article-title":"Clinical characteristics of exogenous progestogen hypersensitivity","volume":"37","author":"Jo","year":"2019","journal-title":"Asian Pac J Allergy Immunol"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/1203475417752370","article-title":"Dermatological manifestations in patients undergoing in vitro fertilization: A prospective study","volume":"22","author":"Sood","year":"2018","journal-title":"J Cutan Med Surg"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0002-9378(72)90181-0","article-title":"The significance of the human corpus luteum in pregnancy maintenance. I. Preliminary studies","volume":"112","author":"Csapo","year":"1972","journal-title":"Am J Obstet Gynecol"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0002-9378(73)90517-6","article-title":"Effects of lutectomy and progesterone replacement therapy in early pregnant patients","volume":"115","author":"Csapo","year":"1973","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.iac.2017.07.006","article-title":"Progestogen hypersensitivity: An evidence-based approach to diagnosis and management in clinical practice","volume":"37","author":"Foer","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/aogs.12771","article-title":"Physiology, production and action of progesterone","volume":"94","author":"Taraborrelli","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R11-20240828","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009154.pub3","article-title":"Luteal phase support for assisted reproduction cycles","author":"Van der Linden","year":"2015","journal-title":"Cochrane Database Syst Rev 2015"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1055\/s-0035-1545363","article-title":"Luteal phase support in in vitro fertilization","volume":"33","author":"Yanushpolsky","year":"2015","journal-title":"Semin Reprod Med"},{"key":"R13-20240828","journal-title":"Controlled ovarian stimulation for IVF\/ICSI 2019 106-12"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.fertnstert.2008.08.064","article-title":"Practice committee of American society for reproductive medicine in collaboration with society for reproductive endocrinology and infertility. Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: An educational bulletin","volume":"90","year":"2008","journal-title":"Fertil Steril"},{"key":"R15-20240828","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009452.pub2","article-title":"Heparin for assisted reproduction","author":"Akhtar","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/humupd\/dmt032","article-title":"Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: A systematic review and meta-analysis","volume":"19","author":"Potdar","year":"2013","journal-title":"Hum Reprod Update"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.fertnstert.2017.04.003","article-title":"Old habits die hard: Retrospective analysis of outcomes with use of corticosteroids and antibiotics before embryo transfer","volume":"107","author":"Kaye","year":"2017","journal-title":"Fertil Steril"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5468\/jwm.2010.3.4.155","article-title":"Efficacy of luteal supplementation of vaginal sildenafil and oral estrogen on pregnancy rate following IVF-ET in women with a history of thin endometria: A pilot study","volume":"3","author":"Kim","year":"2010","journal-title":"Journal of Women's Medicine"},{"key":"R19-20240828","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jaip.2017.01.019","article-title":"Progestogen hypersensitivity: Heterogeneous manifestations with a common trigger","volume":"5","author":"Buchheit","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.autrev.2015.11.003","article-title":"Autoimmune progesterone dermatitis: Update and insights","volume":"15","author":"Nguyen","year":"2016","journal-title":"Autoimmun Rev"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/archdermatol.2008.605","article-title":"Autoimmune progesterone dermatitis","volume":"145","author":"Chawla","year":"2009","journal-title":"Arch Dermatol"},{"key":"R22-20240828","doi-asserted-by":"crossref","first-page":"1121.e9","DOI":"10.1016\/j.fertnstert.2010.10.038","article-title":"Autoimmune progesterone dermatitis: Clinical presentation and management with progesterone desensitization for successful in vitro fertilization","volume":"95","author":"Prieto-Garcia","year":"2011","journal-title":"Fertil Steril"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaad.2007.10.646","article-title":"Autoimmune progesterone dermatitis associated with infertility treatment","volume":"58","author":"Jenkins","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"R24-20240828","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/00007611-196305000-00018","article-title":"Hypersensitivity to gonadal hormones","volume":"56","author":"Meltzer","year":"1963","journal-title":"South Med J"},{"key":"R25-20240828","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jaip.2013.06.005","article-title":"Iatrogenic autoimmune progesterone dermatitis treated with a novel intramuscular progesterone desensitization protocol","volume":"1","author":"Hill","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R26-20240828","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1046\/j.1365-2133.1998.02420.x","article-title":"Autoimmune progesterone dermatitis: Treatment with oophorectomy","volume":"139","author":"R\u00f3denas","year":"1998","journal-title":"Br J Dermatol"},{"key":"R27-20240828","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/00007611-199708000-00016","article-title":"Autoimmune progesterone dermatitis: Onset in a women without previous exogenous progesterone exposure","volume":"90","author":"Moody","year":"1997","journal-title":"South Med J"},{"key":"R28-20240828","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1476-7961-2-10","article-title":"Autoimmune progesterone dermatitis in a patient with endometriosis: Case report and review of the literature","volume":"2","author":"Baptist","year":"2004","journal-title":"Clin Mol Allergy"},{"key":"R29-20240828","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaci.2004.05.031","article-title":"Chronic idiopathic urticaria exacerbated with progesterone therapy treated with novel desensitization protocol","volume":"114","author":"Poole","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"R30-20240828","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.tjog.2013.12.007","article-title":"Autoimmune progesterone dermatitis","volume":"53","author":"Kaygusuz","year":"2014","journal-title":"Taiwan J Obstet Gynecol"},{"key":"R31-20240828","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4168\/aair.2011.3.2.141","article-title":"A case of autoimmune progesterone dermatitis misdiagnosed as allergic contact dermatitis","volume":"3","author":"Lee","year":"2011","journal-title":"Allergy Asthma Immunol Res"},{"key":"R32-20240828","first-page":"308","article-title":"Two cases of autoimmune progesterone dermatitis. Immunohistochemical and serological studies","volume":"69","author":"Miura","year":"1989","journal-title":"Acta Derm Venereol"},{"key":"R33-20240828","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archderm.1969.01610190063011","article-title":"Auto-immune progesterone eczema. An endogenous progesterone hypersensitivity","volume":"99","author":"Jones","year":"1969","journal-title":"Arch Dermatol"},{"key":"R34-20240828","doi-asserted-by":"crossref","first-page":"939083","DOI":"10.3389\/fimmu.2022.939083","article-title":"Whole course of treatment of autoimmune progesterone dermatitis that had spontaneously resolved during pregnancy: A case report and review of the literature","volume":"13","author":"Huang","year":"2022","journal-title":"Front Immunol"},{"key":"R35-20240828","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1210\/jcem-55-3-597","article-title":"Identification of a 17-hydroxyprogesterone-binding immunoglobulin in the serum of a woman with periodic rashes","volume":"55","author":"Cheesman","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"R36-20240828","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1346-8138.2009.00723.x","article-title":"Case of autoimmune progesterone dermatitis presenting as fixed drug eruption","volume":"36","author":"Asai","year":"2009","journal-title":"J Dermatol"},{"key":"R37-20240828","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/014107688507800512","article-title":"Progesterone-induced erythema multiforme","volume":"78","author":"Wojnarowska","year":"1985","journal-title":"J R Soc Med"},{"key":"R38-20240828","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1600-0536.1992.tb00286.x","article-title":"Corticosteroid or steroid allergy?","volume":"26","author":"Schoenmakers","year":"1992","journal-title":"Contact Dermatitis"},{"key":"R39-20240828","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/1346-8138.12473","article-title":"Autoimmune progesterone dermatitis that changed its clinical manifestation from anaphylaxis to fixed drug eruption-like erythema","volume":"41","author":"Honda","year":"2014","journal-title":"J Dermatol"},{"key":"R40-20240828","first-page":"190","article-title":"Autoimmune progesterone dermatitis","volume":"21","author":"Maguire","year":"2009","journal-title":"Dermatol Nurs"},{"key":"R41-20240828","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/jwh.2010.2468","article-title":"A case of progesterone-induced anaphylaxis, cyclic urticaria\/angioedema, and autoimmune dermatitis","volume":"20","author":"Bernstein","year":"2011","journal-title":"J Womens Health (Larchmt)"},{"key":"R42-20240828","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-4632.2008.03395.x","article-title":"Autoimmune progesterone dermatitis. Case report with histologic overlap of erythema multiforme and urticaria","volume":"47","author":"Walling","year":"2008","journal-title":"Int J Dermatol"},{"key":"R43-20240828","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1001\/archderm.1977.01640040034003","article-title":"Autoimmune progesterone dermatitis","volume":"113","author":"Hart","year":"1977","journal-title":"Arch Dermatol"},{"key":"R44-20240828","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/09513590500216735","article-title":"Autoimmune progesterone dermatitis","volume":"22","author":"Cocuroccia","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"R45-20240828","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/archderm.1973.01620210060016","article-title":"Autoimmune progesterone dermatitis of pregnancy","volume":"107","author":"Bierman","year":"1973","journal-title":"Arch Dermatol"},{"key":"R46-20240828","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2796.1990.tb00133.x","article-title":"Autoimmune progesterone dermatitis","volume":"227","author":"Teelucksingh","year":"1990","journal-title":"J Intern Med"},{"key":"R47-20240828","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0091-6749(88)91010-X","article-title":"The treatment of glucocorticosteroid-dependent chronic urticaria with stanozolol","volume":"82","author":"Brestel","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"R48-20240828","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1111\/j.1365-2230.2009.03217.x","article-title":"Autoimmune progesterone dermatitis: Treatment with oophorectomy","volume":"35","author":"Medeiros","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"R49-20240828","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1365-2230.2010.03979.x","article-title":"Autoimmune progesterone dermatitis: A diagnosis easily missed","volume":"36","author":"Toms-Whittle","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"R50-20240828","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0190-9622(95)90398-4","article-title":"Autoimmune progesterone dermatitis","volume":"32","author":"Herzberg","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"R51-20240828","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/09513590009167688","article-title":"Autoimmune progesterone urticaria","volume":"14","author":"Vasconcelos","year":"2000","journal-title":"Gynecol Endocrinol"},{"key":"R52-20240828","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/AOG.0b013e318206cb2c","article-title":"Progesterone autoimmune dermatitis with positiveautologous serum skin test result","volume":"117","author":"Garc\u00eda-Ortega","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R53-20240828","first-page":"239","article-title":"Skin tests with endocrine substances;method of Zondek and Bromberg","volume":"6","author":"Baer","year":"1948","journal-title":"Ann Allergy"},{"key":"R54-20240828","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2310\/6620.2006.05045","article-title":"The role of intradermal skin testing and patch testing in the diagnosis of autoimmune progesterone dermatitis","volume":"17","author":"Stranahan","year":"2006","journal-title":"Dermatitis"},{"key":"R55-20240828","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.anai.2013.06.001","article-title":"Heterogeneity in presentation and treatment of catamenial anaphylaxis","volume":"111","author":"Bauer","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R56-20240828","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/014107688507800512","article-title":"Progesterone-induced erythema multiforme","volume":"78","author":"Wojnarowska","year":"1985","journal-title":"J R Soc Med"},{"key":"R57-20240828","first-page":"311","article-title":"Autoimmune progesterone dermatitis manifested as erythema annulare centrifugum: Confirmation of progesterone sensitivity by in vitro interferon-gamma release","volume":"47","author":"Halevy","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R58-20240828","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJM198411083111907","article-title":"Progesterone sensitivity as a cause of recurrent anaphylaxis","volume":"311","author":"Meggs","year":"1984","journal-title":"N Engl J Med"},{"key":"R59-20240828","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1046\/j.1365-4362.1997.00105.x","article-title":"Autoimmune progesterone dermatitis: Effective prophylactic treatment with danazol","volume":"36","author":"Shahar","year":"1997","journal-title":"Int J Dermatol"},{"key":"R60-20240828","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2133.1994.tb06897.x","article-title":"Progesterone-induced urticaria: Response to buserelin","volume":"130","author":"Yee","year":"1994","journal-title":"Br J Dermatol"},{"key":"R61-20240828","first-page":"542","article-title":"Recurrent anaphylaxis in menstruating women: Treatment with a luteinizing hormone-releasing hormone agonist\u2013a preliminary report","volume":"70","author":"Slater","year":"1987","journal-title":"Obstet Gynecol"},{"key":"R62-20240828","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/AOG.0b013e3181a20721","article-title":"Recurrent postpartum anaphylaxis with breast-feeding","volume":"114","author":"Shank","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R63-20240828","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1079-2104(98)90287-6","article-title":"Autoimmune progesterone dermatitis and stomatitis","volume":"85","author":"Moghadam","year":"1998","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R64-20240828","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archderm.1969.01610250123030","article-title":"Progesterone","volume":"100","author":"Berger","year":"1969","journal-title":"Arch Dermatol"},{"key":"R65-20240828","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1081-1206(10)61838-8","article-title":"Autoimmune progesterone dermatitis and its manifestation as anaphylaxis: A case report and literature review","volume":"90","author":"Snyder","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R66-20240828","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jaip.2017.01.003","article-title":"Anaphylaxis due to progesterone hypersensitivity successfully treated with omalizumab","volume":"5","author":"Heffler","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R67-20240828","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11882-020-0900-4","article-title":"Progestogen Sensitization: A Unique Female Presentation of Anaphylaxis","volume":"20","author":"Bernstein","year":"2020","journal-title":"Curr Allergy Asthma Rep"},{"key":"R68-20240828","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2008.02.044","article-title":"Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases","volume":"122","author":"Castells","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"R69-20240828","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jaci.2009.09.009","article-title":"Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment","volume":"124","author":"Brennan","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R70-20240828","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jaip.2015.12.019","article-title":"Safety, costs, and efficacy of rapid drug desensitizations to chemotherapy and monoclonal antibodies","volume":"4","author":"Sloane","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R71-20240828","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0190-9622(96)90055-9","article-title":"Drug-induced progesterone dermatitis","volume":"34","author":"Fisher","year":"1996","journal-title":"J Am Acad Dermatol"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_664_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:26:43Z","timestamp":1787768803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_664_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_664_22","relation":{},"ISSN":["2229-5178","2249-5673"],"issn-type":[{"value":"2229-5178","type":"print"},{"value":"2249-5673","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,13]]},"assertion":[{"value":"2022-12-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}